In Brief: J&J
This article was originally published in The Rose Sheet
Executive Summary
J&J: Johnson & Johnson domestic consumer product sales advanced 8.8% to $729 mil. for the first quarter of 1995, the company announces April 18. "Growth was led by the addition of Neutrogena" in the third quarter of 1994, the company added. The segment accounts for about one-third of J&J's consolidated domestic business, which recorded a 17.8% sales gain to $2.18 bil. for the three months. Internationally, the firm's consumer products revenues climbed 16.1% to $707 mil. "primarily from the strong performance of our business in Brazil," J&J notes. International sales jumped 25.9% to $2.32 bil...